1 – 10 of 624
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dose-response relationships in neuroendocrine tumours treated with peptide receptor radionuclide therapy
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
- 2025
-
Mark
Assessing the feasibility of HPV screening for cervical cancer in pregnant women in Ethiopia
- Contribution to journal › Article
-
Mark
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH) : a randomised, open-label, phase 2/3 superiority trial
- Contribution to journal › Article
-
Mark
Janus kinase 1 inhibitors for treating immune checkpoint inhibitor-induced enterocolitis - report of two filgotinib-treated cases and literature review
- Contribution to journal › Scientific review
-
Mark
Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
- Contribution to journal › Letter
-
Mark
Gender differences in palliative care needs among Swedish cancer patients prior to specialist palliative care referral
- Contribution to journal › Article
-
Mark
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
- Contribution to journal › Article
-
Mark
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
- Contribution to journal › Scientific review
-
Mark
High prevalence of atrial conduction abnormalities in Lewy body disease – a marker of cardiac complications?
- Contribution to journal › Article
